| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
570,750,000 |
| Market
Cap: |
76.54(M) |
| Last
Volume: |
3,709,408 |
Avg
Vol: |
3,188,549 |
| 52
Week Range: |
$0.1356 - $0.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CytoDyn is a clinical-stage biotechnology company focused on the clinical development of treatments for multiple therapeutic indications based on its product candidate, leronlimab, a humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor. Leronlimab is being investigated as a viral entry inhibitor for Human Immunodeficiency Virus. Leronlimab is also being studied in oncology, as well as other therapeutic indications, including coronavirus disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dembow George F |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,743 |
320,959 |
|
- |
|
| Gould Gregory A |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,743 |
8,743 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,743 |
1,270,143 |
|
- |
|
| Tropp Ronald J |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,743 |
3,743 |
|
- |
|
| Caracciolo Anthony |
Director |
– • – |
2012-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,703 |
51,703 |
|
- |
|
| Dembow George F |
Director |
– • – |
2012-05-07 |
4 |
S |
$2.02 |
$14,494 |
D/D |
(7,175) |
317,216 |
|
- |
|
| Dembow George F |
Director |
– • – |
2012-05-02 |
4 |
S |
$2.00 |
$3,000 |
D/D |
(1,500) |
324,391 |
|
- |
|
| Dembow George F |
Director |
– • – |
2012-05-01 |
4 |
S |
$2.07 |
$24,859 |
D/D |
(12,009) |
325,891 |
|
- |
|
| Naydenov Jordan G |
Director |
– • – |
2012-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
600,000 |
1,266,400 |
|
- |
|
| Dembow George F |
Director |
– • – |
2012-01-24 |
4 |
S |
$2.71 |
$81,300 |
D/D |
(30,000) |
337,500 |
|
- |
|
| Caracciolo Anthony |
Director |
– • – |
2011-12-21 |
4 |
B |
$1.50 |
$75,000 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2011-08-12 |
5 |
S |
$1.92 |
$14,682 |
I/I |
(7,647) |
60,080 |
|
- |
|
| Van Ness Kenneth |
CEO & President |
• • • |
2011-04-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(728,000) |
0 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2011-03-09 |
5 |
S |
$1.90 |
$19,000 |
I/I |
(10,000) |
67,727 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2011-02-11 |
5 |
B |
$1.95 |
$195 |
I/I |
100 |
77,727 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2011-01-25 |
5 |
S |
$1.77 |
$6,181 |
I/I |
(3,500) |
77,627 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2011-01-24 |
5 |
S |
$1.85 |
$2,960 |
I/I |
(1,600) |
81,127 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-12-03 |
5 |
S |
$1.17 |
$2,340 |
I/I |
(2,000) |
82,727 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-12-01 |
5 |
S |
$1.15 |
$11,500 |
I/I |
(10,000) |
84,727 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-30 |
5 |
S |
$1.15 |
$12,650 |
I/I |
(11,000) |
95,477 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-29 |
5 |
S |
$1.17 |
$9,360 |
I/I |
(8,000) |
106,477 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-26 |
5 |
S |
$1.20 |
$5,340 |
I/I |
(4,450) |
114,477 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-22 |
5 |
S |
$1.23 |
$2,460 |
I/I |
(2,000) |
118,927 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-19 |
5 |
S |
$1.20 |
$5,940 |
I/I |
(4,950) |
120,927 |
|
- |
|
| Pourhassan Nader |
Chief Operating Officer |
• – – |
2010-11-16 |
5 |
A |
$0.00 |
$0 |
D/D |
150,000 |
209,100 |
|
- |
|
381 Records found
|
|
Page 9 of 16 |
|
|
